Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1-STAT3/NF-κB signaling

Research output: Contribution to journalArticle

23 Scopus citations
Original languageEnglish (US)
Pages (from-to)14745-14750
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume113
Issue number51
DOIs
StatePublished - Dec 20 2016

Keywords

  • GHRH receptor
  • GHRH-R antagonist
  • PAK1
  • Prognostic predictor
  • Stomach cancer

ASJC Scopus subject areas

  • General

Cite this

Gan, J., Ke, X., Jiang, J., Dong, H., Yao, Z., Lin, Y., Lin, W., Wu, X., Yan, S., Zhuang, Y., Chu, W. K., Cai, R., Zhang, X., Cheung, H. S., Block, N. L., Pang, C. P., Schally, A. V., & Zhang, H. (2016). Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1-STAT3/NF-κB signaling. Proceedings of the National Academy of Sciences of the United States of America, 113(51), 14745-14750. https://doi.org/10.1073/pnas.1618582114